Search results
Julie Louise Gerberding (born August 22, 1955) is an American infectious disease expert who was the first woman to serve as the director of the U.S. Centers for Disease Control and Prevention (CDC). As of May 2022, she is the CEO of the Foundation for the National Institutes of Health (FNIH).
Mar 1, 2022 · KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Dr. Julie L. Gerberding, chief patient officer and executive vice president, population health and sustainability, will be retiring from Merck in May 2022.
Mar 1, 2022 · North Bethesda, MD, March 1, 2022 – The Foundation for the National Institutes of Health (FNIH) today announced the appointment of Dr. Julie Louise Gerberding, the 15th Director of the Centers for Disease Control and Prevention (CDC) and an executive at Merck & Co., Inc., as its next Chief Executive Officer. Dr.
Mar 18, 2022 · The Foundation for the National Institutes of Health appointed Dr. Julie Louise Gerberding as its next chief executive officer. She will assume her role on May 16.
View Julie Gerberding’s profile on LinkedIn, a professional community of 1 billion members. Dr. Julie Louise Gerberding is the CEO of the Foundation for the National Institutes of…
- Foundation for the National Institutes of Health
Dec 10, 2014 · today announced the appointment of Dr. Julie Gerberding, 59, as executive vice president for strategic communications, global public policy and population health, effective Dec. 15. In this newly created Executive Committee position, Gerberding, who most recently served as president of Merck Vaccines, will be responsible for Merck’s global
Julie Louise Gerberding was born in Estelline, South Dakota in 1955. She attended Case Western Reserve University as an undergraduate, where she stayed on to earn her M.D. degree, graduating in 1981. That year she also received the university's Alice Paige Cleveland Award as an outstanding medical graduate.
Related searches
